HCS is focused on rounds A and B, within a variety of segments in the High Tech and Life Sciences ecosystems, while having the flexibility to invest earlier, as well as “stay for the course” through the growth stage. HCS has substantial involvement in the strategy, business development and fundraising aspects of portfolio companies, relying on its experienced Israeli team, as well as the experience and global network of its investors.